Showing results (71-80 of 128) with videos related to

Sort By:
Pageof 13
ACS Chemical Neuroscience|September 19, 2024
Functional Characterization of an Arylsulfonamide-Based Small-Molecule Inhibitor of the NLRP3 InflammasomeSavannah Biby, Prasenjit Mondal, Yiming Xu, et al.
Molecular Pharmaceutics|November 6, 2024
Molecular Imaging Reveals Antineuroinflammatory Effects of HDAC6 Inhibition in Stroke ModelsYanting Zhou, Chen Li, Rui Wu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 22, 2023
Structure-Based Discovery of A Small Molecule Inhibitor of Histone Deacetylase 6 (HDAC6) that Significantly Reduces Alzheimer's Disease NeuropathologyPrasenjit Mondal, Ping Bai, Ashley Gomm, et al.
Nuclear Medicine and Biology|August 20, 2013
Evaluation of potential PET imaging probes for the orexin 2 receptorsChangning Wang, Colin M Wilson, Christian K Moseley, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|May 13, 2022
Design, synthesis, and evaluation of novel <i>O</i>-alkyl ferulamide derivatives as multifunctional ligands for treating Alzheimer's diseaseGaofeng Zhu, Ping Bai, Keren Wang, et al.
Journal of Medicinal Chemistry|November 21, 2025
Development and Preclinical Evaluation of Novel F-18-Labeled Dihydropyrazole RIPK1 PET Tracers for Neuroinflammation ImagingHongyan Li, Zeyi Qin, Yanting Zhou, et al.
Journal of Medicinal Chemistry|December 27, 2023
Design and Discovery of Novel NLRP3 Inhibitors and PET Imaging Radiotracers Based on a 1,2,3-Triazole-Bearing ScaffoldYiming Xu, Yulong Xu, Savannah Biby, et al.
European Journal of Medicinal Chemistry|October 4, 2024
PET imaging assist investigation of HDAC6 expression change in MDD and evaluating antidepressant efficacy of a newly developed HDAC6 inhibitorXiao Zhong, Xiaoai Wu, Yanting Zhou, et al.
ACS Chemical Neuroscience|December 18, 2015
Development of a Fluorinated Class-I HDAC Radiotracer Reveals Key Chemical Determinants of Brain PenetranceMartin G Strebl, Changning Wang, Frederick A Schroeder, et al.
Pageof 13